Table 1.
Association between CNALPTC1 expression and clinicopathological characteristics of PTC patients
| Clinicopathologic characteristics | CNALPTC1 | P-value | |
|---|---|---|---|
|
| |||
| Low | High | ||
| All cases | 32 | 32 | |
| Gender | 0.412 | ||
| Male | 8 | 11 | |
| Female | 24 | 21 | |
| Age (years) | 0.211 | ||
| < 45 | 18 | 13 | |
| ≥45 | 14 | 19 | |
| Focality | 1.000 | ||
| Unifocal | 19 | 19 | |
| Multifocal | 13 | 13 | |
| Primary tumor | 0.008 | ||
| T1-T2 | 26 | 16 | |
| T3-T4 | 6 | 16 | |
| Lymph node metastasis | 0.005 | ||
| N0 | 18 | 7 | |
| N1 | 14 | 25 | |
| TNM stage | 0.017 | ||
| I-II | 26 | 17 | |
| III-IV | 6 | 15 | |
Median expression level of CNALPTC1 was used as the cutoff. P-value was acquired by Pearson chi-square test.